Work

SA70 Patient-Reported Outcomes and Daily Activity Assessed with a Digital Wearable Device (FITBIT™) in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: The Reveal Study

Year: 2023

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2023.03.2740

Authors: E.A Griffiths, A. Wang, I. Tomazos, J.S Min, W.N Lee, Y. Patel, J. Yu, D. Dingli

Institutions: Roswell Park Comprehensive Cancer Center, Alexion Pharmaceuticals (United States), Evidation Health (United States), Mayo Clinic

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4380148839

Cites:

Cited by:

Related to: 10